Rallybio CFO Jonathan Lieber shifts to part-time role, keeps finance chief post
RLYB•CFO shifts to part-time status ahead of merger closing
Rallybio CFO Jonathan Lieber will shift to part-time status effective Sept. 15, 2026.
Lieber’s employment is set to end when the pending business combination with Avenzo Therapeutics closes.
